Loading...

Masimo Corp
NASDAQ:MASI

Watchlist Manager
Masimo Corp Logo
Masimo Corp
NASDAQ:MASI
Watchlist
Price: 144.94 USD +3.05% Market Closed
Updated: Dec 1, 2022

Intrinsic Value

The intrinsic value of one MASI stock under the Base Case scenario is 127.91 USD. Compared to the current market price of 144.94 USD, Masimo Corp is Overvalued by 12%.

The Intrinsic Value is calculated as the average of the two valuation methods:

MASI Intrinsic Value
Base Case
127.91 USD
Overvaluation 12%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

MASI Profitability Score
Profitability Due Diligence

Masimo Corp's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

64/100
Profitability
Score

Masimo Corp's profitability score is 64/100. The higher the profitability score, the more profitable the company is.

MASI Solvency Score
Solvency Due Diligence

Masimo Corp's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Positive Net Debt
Long-Term Liabilities
Low D/E
Short-Term Liabilities
70/100
Solvency
Score

Masimo Corp's solvency score is 70/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
55%
Gross Margin
13%
Operating Margin
10%
Net Margin
4%
FCF Margin
13%
ROE
10%
ROIC
Other

MASI Capital Structure
Masimo Corp

Market Capitalization 7.6B USD
Total Debt 951M USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 220M USD
Short-Term Investments 0 USD
Enterprise Value 8.4B USD

Wall St
Price Targets

MASI Price Targets Summary
Masimo Corp

Wall Street analysts forecast MASI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MASI is 155.67 USD .

Lowest
Price Target
Not Available
Average
Price Target
155.67 USD
7% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

MASI Competitors
Masimo Corp

Ownership

MASI Shareholders
Major Shareholders

Insiders don't own a significant part of the company.

Top 25 shareholders own 54.67% of the company. Insiders own 1.25%. The biggest insider is Kiani Joe E (CEO and Chairman of the Board), who owns 0.2348% of Masimo Corp.

Insiders
1.25%
Institutions
78.98%
Other
19.77%
Insiders
1.25%
Kiani Joe E
CEO and Chairman of the Board
Ownership
0.2348%
Market Value
17.9M USD
Shares
123 399
Lee Yongsam
EVP, CIO
Ownership
0.1831%
Market Value
13.9M USD
Shares
96 230
Barker Steven
Director
Ownership
0.1475%
Market Value
11.2M USD
Shares
77 549
Reynolds Craig B
Director
Ownership
0.1078%
Market Value
8.2M USD
Shares
56 657
Fitch Sanford
Director
Ownership
0.1037%
Market Value
7.9M USD
Shares
54 522
Mcclenahan Thomas Samuel
EVP, GEN COUNSEL & CORP SEC
Ownership
0.0802%
Market Value
6.1M USD
Shares
42 151
Muhsin Bilal
Chief Operating Officer
Ownership
0.0697%
Market Value
5.3M USD
Shares
36 619
Sampath Anand
EVP, Ops & Clinical Research
Ownership
0.0651%
Market Value
5M USD
Shares
34 226
Coleman Jon
Pres-WW OEM & Global Health
Ownership
0.0626%
Market Value
4.8M USD
Shares
32 909
Levy Tao
EVP, Bus Dev
Ownership
0.0519%
Market Value
4M USD
Shares
27 257
Young Micah W
EVP & Chief Financial Officer
Ownership
0.0505%
Market Value
3.8M USD
Shares
26 557
Duffy Kevin P
President, Consumer
Ownership
0.0359%
Market Value
2.7M USD
Shares
18 893
Harkin Thomas
Director
Ownership
0.022%
Market Value
1.7M USD
Shares
11 557
Mikkelson Adam
Director
Ownership
0.0108%
Market Value
825k USD
Shares
5 691
Shimer Julie Ann
Director
Ownership
0.0084%
Market Value
639k USD
Shares
4 410
Cohen H Michael
Director
Ownership
0.0073%
Market Value
554k USD
Shares
3 823
Koning John Todd
SVP, Chief Accounting Officer
Ownership
0.0028%
Market Value
215k USD
Shares
1 483
Van Ramshorst David J
SVP, Chief Accounting Officer
Ownership
0.0019%
Market Value
145k USD
Shares
1 000
Institutions
78.98%
Back

MASI Insider Trading
Buy and sell transactions by insiders

Masimo Corp insiders have bought more shares than they have sold in the past 12 months.

During the last 12 months Masimo Corp insiders bought 5M USD , and sold 1.2M USD worth of shares. The last transaction was made on Dec 1, 2022 by Kiani Joe E (CEO and Chairman of the Board), who bought 4M USD worth of MASI shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
1.2M USD
3
Bought
0-3
months
1
5M USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
5M USD
5M
6 Months
N/A
5M USD
5M
9 Months
N/A
5M USD
5M
12 Months
1.2M USD
5M USD
3.7M
Purchases
11
Sales
407
Why is insider trading important?

Shareholder Return

MASI Price
Masimo Corp

1M 1M
+10%
6M 6M
+6%
1Y 1Y
-47%
3Y 3Y
-7%
5Y 5Y
+63%
Annual Price Range
144.94
52w Low
110.88
52w High
297.23
Price Metrics
Average Annual Return 34.35%
Standard Deviation of Annual Returns 31.15%
Max Drawdown -63%

Company Profile

Masimo Corp

Country

United States of America

Industry

Health Care

Market Cap

7.6B USD

Dividend Yield

0%

Description

Masimo Corp. is a medical technology company, which develops, manufactures and markets noninvasive patient monitoring technologies, medical devices and sensors. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The firm's patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners. The company has developed Masimo Signal Extraction Technology (SET), which provides the capabilities of Measure-through Motion and Low Perfusion pulse oximetry to address the primary limitations of conventional pulse oximetry. The firm's technology offerings also include remote patient monitoring, connectivity, and hospital automation solutions, including Masimo Patient SafetyNet and Masimo Patient SafetyNet Surveillance.

Contact

CALIFORNIA
Irvine
52 Discovery
+19492977000.0
https://www.masimo.com/

IPO

2007-08-08

Employees

2 200

Officers

Founder, CEO & Chairman
Mr. Joseph E. Kiani
Exec. VP of Fin. & CFO
Mr. Micah Young
Chief Operating Officer
Mr. Bilal Muhsin
Exec. VP, Gen. Counsel & Corp. Sec.
Mr. Thomas Samuel McClenahan
Exec. VP of Bus. Devel.
Mr. Tao Leopold Levy
Exec. VP & Chief Information Officer
Mr. Yongsam Lee
Show More
Chairman of Scientific Advisory Board & Chief Science Officer
Dr. Steven J. Barker
VP of Bus. Devel. & Investor Relations
Mr. Eli Kammerman
Pres of Worldwide Sales, Professional Services & Medical Affairs
Mr. Jon Coleman
Exec. VP of Operations & Clinical Research
Mr. Anand Sampath
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one MASI stock?

The intrinsic value of one MASI stock under the Base Case scenario is 127.91 USD.

Is MASI stock undervalued or overvalued?

Compared to the current market price of 144.94 USD, Masimo Corp is Overvalued by 12%.